STOCK TITAN

Lanvin Group Receives Continued Listing Standard Notice from NYSE

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

Lanvin Group (NYSE: LANV) received a notice on November 10, 2026, that it failed the NYSE's minimum share-price listing standard.

The standard requires an average closing price of at least US$1.00 over 30 consecutive trading days. The company has six months after receipt to regain compliance and has notified the NYSE of its intent to cure the deficiency. Lanvin Group intends to consider alternatives, including a reverse stock split subject to shareholder approval if necessary. The notice has no immediate effect on its listing; trading continues subject to other NYSE listing requirements. The company does not anticipate an impact on ongoing operations.

Loading...
Loading translation...
0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major pointNYSE listing deficiency reflects failure to meet the US$1.00 average closing-price requirement over 30 consecutive trading days.
  • Minor pointSix-month cure period follows receipt of the November 10, 2026 deficiency notice.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Potential reverse stock split to address non-compliance would require shareholder approval if pursued.

News Explained

If used, Lanvin’s possible reverse split would reduce the share count and raise the per-share price proportionally, while the split does not change company value.

For the NYSE deficiency, regaining compliance requires a closing price of at least US$1.00 on the last trading day of a cure-period month, as well as a 30-trading-day average closing price of at least US$1.00.

Key Figures

Minimum share price: US$1.00 per share Cure period: Six months Notice response deadline: Ten business days +1 more
Minimum share price
US$1.00 per share
NYSE test requires both a month-end closing price and a 30-trading-day average at or above this level
Cure period
Six months
Following receipt of the deficiency letter
Notice response deadline
Ten business days
Period to notify the NYSE of intent to cure; the company says it has notified the NYSE
Prior daily close
$0.7201
LANV close on Nov 12, 2026, before article publication

Key Terms

reverse stock split
1 terms
reverse stock split financial
"including but not limited to a reverse stock split"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SHANGHAI, Nov. 13, 2026 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV) ("Lanvin Group" or the "Company"), a global luxury fashion group, today announced that it received a notice from the New York Stock Exchange (the "NYSE") on November 10, 2026 that the Company is not in compliance with the NYSE's continued listing standard requiring a minimum average closing price of US$1.00 per share for its ordinary shares over a consecutive 30 trading-day period.

The Company has notified the NYSE within ten business days of receipt of the notice of its intent to cure the deficiency. Pursuant to the NYSE's rules, the Company has a six-month period following receipt of the deficiency letter to regain compliance with the minimum share price requirement.

The Company intends to consider available alternatives, including but not limited to a reverse stock split that is subject to shareholder approval, if necessary to cure the stock price non-compliance.  The Company can regain compliance at any time during the six-month cure period if, on the last trading day of any calendar month during the cure period, the Ordinary Shares have a closing price of at least US$1.00 per share and an average closing price of at least US$1.00 per share over the 30 trading-day period ending on the last trading day of that month.

The NYSE notice has no immediate effect on the continued listing of Lanvin Group's ordinary shares on the NYSE and is not anticipated to impact the Company's ongoing business operations. The Company's ordinary shares will continue to be listed and trade on the NYSE under the symbol "LANV" during this period, subject to the Company's compliance with the NYSE's other continued listing requirements.

About Lanvin Group

Lanvin Group is a leading global luxury fashion group headquartered in Shanghai, China, and Milan, Italy, managing iconic brands worldwide including Lanvin, Wolford, Sergio Rossi and St. John Knits. Leveraging its unique strategic alliances with industry-leading partners in the luxury fashion sector and its access to the fastest-growing luxury fashion markets, Lanvin Group strives to expand the global footprint of its portfolio brands and achieve sustainable growth through strategic investment and extensive operational know-how. Lanvin Group's ordinary shares are listed on the New York Stock Exchange under the ticker symbol "LANV".  For more information about Lanvin Group, please visit www.lanvin-group.com, and to view Lanvin Group's investor presentation, please visit https://ir.lanvin-group.com.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this press release are forward-looking statements, including, without limitation, statements regarding the Company's intention and ability to regain compliance with the NYSE's continued listing standards within the applicable cure period or at all; the continued listing and trading of the Company's ordinary shares on the NYSE; the options the Company may pursue to regain compliance; and the anticipated impact of the NYSE notice on the Company's business operations. In some cases, forward-looking statements can be identified by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seek," "future," "outlook" and "project" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these identifying words.

These forward-looking statements are based on the Company's current expectations and assumptions, are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors, many of which are beyond the Company's control, that could cause actual results to differ materially from those expressed or implied by these statements, including, without limitation, the market price of the Company's ordinary shares and whether it will recover to and remain at or above US$1.00 per share for the required period; whether any option the Company pursues will be successful; the Company's ability to continue to satisfy the NYSE's other continued listing standards; and the other risks and uncertainties described under "Item 3. Key Information—D. Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC") on April 30, 2026, and in the Company's other filings with the SEC.

Forward-looking statements speak only as of the date of this press release. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contacts

Media & Investors
Lanvin Group Holdings Limited
Ross Luo
ross.luo@lanvin-group.com
Coco Wang
coco.wang@lanvin-group.com

Cision View original content:https://www.prnewswire.com/news-releases/lanvin-group-receives-continued-listing-standard-notice-from-nyse-302938800.html

SOURCE Lanvin Group

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Lanvin Group (LANV) receive an NYSE listing notice?

Lanvin Group failed to meet the NYSE requirement for a minimum average closing price of US$1.00 per share over 30 consecutive trading days. It received the deficiency notice on November 10, 2026; the notice has no immediate effect on its continued listing.

How can Lanvin Group (LANV) regain compliance with the NYSE share-price requirement?

During the six-month cure period, Lanvin Group can regain compliance if its shares close at at least US$1.00 on the last trading day of a calendar month and average at least US$1.00 over the 30 trading-day period ending that day.

Keep reading